You are here

  • Home
  • Archive
  • Volume 81, Issue 12
  • Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink

Article info

Article menu
Download PDFPDF
Letter
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink

Authors

  1. Correspondence to Professor Abhishek Abhishek, Academic Rheumatology, University of Nottingham, Nottingham NG7 2RD, Nottinghamshire, UK; abhishek.abhishek{at}nottingham.ac.uk
View Full Text

Citation

Abhishek A, Cipolletta E, Nakafero G, et al
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink
Annals of the Rheumatic Diseases 2022;81:1768-1769.

Publication history

  • Received April 16, 2022
  • Accepted June 20, 2022
  • First published June 30, 2022.
Online issue publication 
September 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.